DFTX CIK: 1813814

Definium Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.8
FY22:
−50.1
FY23:
−64.4
FY24:
−79.1
FY25:
−132
Change from FY21 to FY25
millions USD
FY21:
−0.30
FY22:
–
FY23:
–
FY24:
0
FY25:
−152
Change from FY21 to FY25
millions USD
FY21:
98.8
FY22:
59.1
FY23:
21.8
FY24:
253
FY25:
267
millions USD
FY21:
53.4
FY22:
8.60
FY23:
−42.4
FY24:
174
FY25:
−15.9

All amounts in millions USD Data source:SEC EDGAR